clinical trial. The primary physicians should then talk to their patients about the clinical trial and ascertain their interest in participation in that trial. The patients can contact the investigators directly. Alternatively they can provide written authorization to their physicians, allowing the physicians to contact the investigators. Direct contact of patients by the honest broker ("cold-calling") is prohibited by IRE regulations. This honest broker system Use by repositories other than the University of Pittsburgh: has been used by entities other than the University of Pittsburgh. A similar model has been applied by the Cooperative Prostate Cancer Tissue Resource [3, 8, 9] as well as the Pennsylvania Cancer Alliance Bioinformatics Consortium. In addition, similar protocols were adopted for case retrieval for the Shared Pathology Informatics Network (SPIN) validation studies [10].
clinical trial. The primary physicians should then talk to their patients about the clinical trial and ascertain their interest in participation in that trial. The patients can contact the investigators directly. Alternatively they can provide written authorization to their physicians, allowing the physicians to contact the investigators. Direct contact of patients by the honest broker ("cold-calling") is prohibited by IRE regulations. Use by repositories other than the University of Pittsburgh: This honest broker system has been used by entities other than the University of Pittsburgh. A similar model has been applied by the Cooperative Prostate Cancer Tissue Resource [3, 8, 9] as well as the Pennsylvania Cancer Alliance Bioinformatics Consortium. In addition, similar protocols were adopted for case retrieval for the Shared Pathology Informatics Network (SPIN) validation studies [10].
12885_2008_1174_MOESM1_ESM.docx